• YF-VAX

    May 23, 2025

    For active immunization for the prevention of yellow fever in persons 9 months of age and older for persons living in or travelling to endemic areas, persons travelling internationally through countries with yellow fever, and laboratory personnel who handle virulent yellow fever virus.

    Coronavirus (COVID-19) | CBER-Regulated Biologics

    May 22, 2025

    This page and the associated links provide information on guidance and advice relevant to the development of therapies to treat or prevent COVID-19, and contact information for developers seeking additional information or assistance.

    Flublok Quadrivalent

    May 22, 2025

    Flublok Quadrivalent is a vaccine indicated for active immunization against disease caused by influenza A subtype viruses and influenza type B viruses contained in the vaccine. Flublok Quadrivalent is approved for use in persons 18 years of age and older.